A carregar...
Converting biology into clinical benefit: lessons learned from BRAF inhibitors
The identification and pharmacological targeting of activating BRAF mutations in melanoma has led to significant improvements in patient outcomes. This perspective paper illustrates the lessons learned from the study of BRAF mutations and the development of BRAF inhibitors. The relevance of these le...
Na minha lista:
| Publicado no: | Melanoma Manag |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4649930/ https://ncbi.nlm.nih.gov/pubmed/26594316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt.15.18 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|